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Clinical Trial
MTWA Does Not Predict Arrhythmias in ICD Patients
Testing for microvolt T-wave alternans (MTWA) may help to predict the risk ofventricular tachyarrhythmic events (VTEs). The MASTER trial evaluated the
utility of MTWA in post-infarction prophylactic defibrillator (implantable
cardioverter-defibrillator [ICD]) recipients. After 2 years of follow-up, there was no
significant difference in VTEs between MTWA non-negative and MTWA negative
patients. MTWA does not appear to be a sufficient discriminator of risk to be used for
decisions regarding the necessity of ICD implantation.Seepage1607.Seefigure.
Interventional Cardiology
Bioabsorbable Stents May Have More Late Stent Recoil
Bioabsorbable polymer stents aremoreflexible thanmetallic stents and are designedto be fully metabolized and absorbed over 2 to 3 years. Tanimoto and colleagues
repeated intravascular ultrasound images in patients who had received a bioabsorbable
everolimus-eluting coronary stent 6 months earlier. The mean reduction in cross-
sectional area was 0.65 mm2 or 7.6%. This compares to 0.6% for the Palmaz-Schatz
stent and 0.3% for the XIENCE V stent seen in earlier studies. These results suggest
that bioabsorbable polymer stents do have more stent recoil than metallic stents.
See page 1616.
Interventional Cardiology
SES Superior to BA for ISR: Long-Term Results
The RIBS-II study randomized patients with in-stent restenosis (ISR) to eithersirolimus-eluting stent (SES) or balloon angioplasty (BA). At 1 year, subjects
assigned to SES had a lower restenosis rate (11% vs. 39%). This article focuses on
outcomes over the subsequent 3 years. There were similar rates of death, myocardial
infarction, and target vessel revascularization, with similar low rates of stent thrombo-
sis. The event-free survival was higher in the SES arm (76% vs. 65%). The improved
outcomes with SES for ISR are maintained up to 4 years after intervention with no
evidence of a late “catch-up.” See page 1621.
(continued on page A-24)
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NSAIDs and
Myocardial Infarction
Risk of MI With NSAIDs Linked to Degree of COX-2 Inhibition
Garcı´a Rodrı´guez and colleagues studied the association between the frequency,dose, and duration of use of nonsteroidal anti-inflammatory drugs (NSAIDs)
and the risk ofmyocardial infarction (MI). The hazard ratio for current users was 1.35.
The risk increased with treatment duration and dose, and there was a significant
correlation between the degree of inhibition of cyclooxygenase (COX)-2, but not
COX-1. This study suggests that the degree of inhibition of COX-2 is a surrogate
predictor of the relative increased risk of MI by NSAIDs. See pages 1628 and
1637. See figure.
Page 1644
Heart Failure
Differences in Etiology of HF and Clinical Outcomes Across the World
Blair and colleagues used data collected during the EVEREST trial to examinedifferences in the presentation and management of heart failure (HF) by geo-
graphical location. Subjects were divided into 4 geographic regions: North America,
South America, Western Europe, and Eastern Europe. There were significant differ-
ences in unadjusted 1-year mortality, cardiovascular mortality, hospitalization for HF,
etiology of HF, and comorbidities by region. The heterogeneous outcomes were
related to differences in severity, etiology, and management of HF and need to be
considered when planning global clinical trials for patients with HF. See pages
1640 and 1649. See figure.
Page 1658
Pre-Clinical Research
Imaging Transplanted Stem Cells Made Possible by Transfection
Terrovitis and colleagues wanted to develop a technique that would allow in vivoimaging of viable transplanted stem cells. Rat cardiac-derived stem cells (rCDCs)
were transfected with the gene for the sodium-iodide symporter (NIS), which pro-
motes cellular uptake of technetium99m (99mTc) or iodine 124 (124I). The transfected
cells were then injected into the myocardium shortly after ligation of the left anterior
descending artery. Cells were visualized as regions of 99mTc or 124I uptake on single-
photon emission computed tomography and positron emission tomography images,
respectively. This approach allows for stem cell tracking using clinically available
imaging modalities. See pages 1652 and 1661. See figure.(continued on page A-28)
(continued) A-28News From the NCDR
Prior CABG Associated With Longer DTB Times
Kim and colleagues queried the National Cardiovascular Data Registry (NCDR)to determine whether a prior history of coronary artery bypass graft (CABG)
surgery correlates with prolonged door-to-balloon (DTB) times among ST-segment
elevation myocardial infarction patients. In the 70,000 patients examined, median
DTB time was 15min longer in patients with prior CABG (113min vs. 98min), and
only 40% of patients with CABG had a DTB 90 min. This analysis finds that a
history of CABG surgery is associated with significantly prolonged DTB, which may
substantially impact the performance measurement for a given hospital depending on
the case mix. See page 1665.
Year in Cardiology Series
The Year in Heart Failure
Tang and Francis summarize the year’s most relevant publications related to heartfailure. The articles are placed in context and arranged into categories including
genetics, biomarkers, and treatment strategies. They conclude that the reliance on
mega-trials to formulate clinical evidence for the treatment of heart failure is becoming
outdated, with a new emphasis needed on individualized therapy based on genetic,
biochemical, and echocardiographic profiling. See page 1671.
